Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.96 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.96 |
| ▸ | CHRM3 | P20309 | 11/20 | 0.57 |
| ▸ | CHRM2 | P08172 | 9/20 | 0.57 |
| ▸ | CHRM1 | P11229 | 8/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.51 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.51 |
| ▸ | HRH1 | P35367 | 1/20 | 0.51 |
| ▸ | HTR2B | P41595 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1235433 | 1.00 | KEAP1 (0.96) | KEAP1NFE2L2CHRM3CHRM2CHRM1 | |
| SCHEMBL2764243 | 1.00 | KEAP1 (0.96) | KEAP1NFE2L2CHRM3CHRM2CHRM1 | |
| SCHEMBL3909615 | 1.00 | KEAP1 (0.96) | KEAP1NFE2L2CHRM3CHRM2CHRM1 | |
| SCHEMBL198312 | 1.00 | KEAP1 (0.96) | KEAP1NFE2L2CHRM3CHRM2CHRM1 | |
| SCHEMBL29903954 | 1.00 | KEAP1 (0.96) | KEAP1NFE2L2CHRM3CHRM2CHRM1 | |
| Hydrochloric Acid SCHEMBL6004238 | 0.98 | KEAP1 (0.93) | KEAP1NFE2L2CHRM3CHRM2CHRM1 | |
| Hydrochloric Acid SCHEMBL8197629 | 0.98 | KEAP1 (0.93) | KEAP1NFE2L2CHRM3CHRM2CHRM1 | |
| Hydrochloric Acid SCHEMBL8204903 | 0.98 | KEAP1 (0.93) | KEAP1NFE2L2CHRM3CHRM2CHRM1 | |
| Water SCHEMBL8898031 | 0.98 | KEAP1 (0.93) | KEAP1NFE2L2CHRM3CHRM2CHRM1 | |
| SCHEMBL415801 | 0.98 | KEAP1 (1.00) | KEAP1NFE2L2CHRM3CHRM2CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 501 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4297725-B1 | SYRINGE STERILIZATION METHOD | FARCO GMBH (DE) | 2024-10-23 | — | — | EP | claimed |
| EP-4360669-A2 | METHOD FOR SYRINGE STERILIZATION | Farco-Pharma GmbH (DE) | 2024-05-01 | — | — | EP | claimed |
| EP-4297725-A1 | SYRINGE STERILIZATION METHOD | Farco-Pharma GmbH (DE) | 2024-01-03 | — | — | EP | claimed |
| WO-2023214426-A1 | PROCESS FOR THE PREPARATION OF R-OXYBUTYNIN HYDROCHLORIDE | HARMAN FINOCHEM LIMITED (IN) | 2023-11-09 | — | — | WO | claimed |
| WO-2022223174-A1 | SYRINGE STERILIZATION METHOD | FARCO-PHARMA GMBH (DE) | 2022-10-27 | — | — | WO | claimed |
| CN-114805100-A | Preparation method of oxybutynin hydrochloride | 南京亿华药业有限公司 | 2022-07-29 | — | — | CN | claimed |
| US-10449173-B2 | Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions | ALLERGAN SALES, LLC (US) | 2019-10-22 | — | — | US | claimed |
| EP-3287122-B1 | DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS FOR TREATING OVERACTIVE BLADDERS. | ALLERGAN SALES LLC (US) | 2019-04-17 | — | — | EP | claimed |
| EP-3287122-A1 | A METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | Allergan Sales, LLC (US) | 2018-02-28 | — | — | EP | claimed |
| EP-2427172-B1 | A METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | ALLERGAN SALES LLC (US) | 2017-11-01 | — | — | EP | claimed |
| EP-1205464-A2 | Production method of 2-cyclohexyl-2-hydroxy-2-phenylacetic acid intermediate therefor and production method thereof | SUMIKA FINE CHEMICALS Co., Ltd. (JP) | 2002-05-15 | — | — | EP | claimed |
| EP-1185498-A2 | SYNTHESIS OF OPTICALLY ACTIVE CYCLOHEXYLPHENYLGLYCOLIC ACID AND ITS ESTERS | Sepracor Inc. (US) | 2002-03-13 | — | — | EP | claimed |
| EP-1127043-A1 | STEREOSELECTIVE PROCESS FOR PREPARING (CYCLO)ALKYL PHENYLGLYCOLIC ACIDS | Sepracor Inc. (US) | 2001-08-29 | — | — | EP | claimed |
| US-6180823-B1 | CONDENSING SUBSTITUTED ACETALDEHYDE WITH ENANTIOMER OF MANDELIC ACID TO PROVIDE 5-PHENYL-1,3-DIOXOLAN-4-ONE, CONDENSING WITH CYCLOHEXANONE, DEHYDRATING PRODUCT, HYDROLYZING, REDUCING TO ALPHA-CYCLOHEXYLPHENYLGLYCOLIC ACID | SEPRACOR INC. | 2001-01-30 | — | — | US | claimed |
| US-6140529-A | Synthesis of optically active cyclohexylphenylglycolate esters | SEPRACOR INC. (US) | 2000-10-31 | — | — | US | claimed |
| US-6090971-A | Resolution process for cyclohexylphenyl glycolic acid | SEPRACOR INC. (US) | 2000-07-18 | — | — | US | claimed |
| WO-2000027786-A1 | STEREOSELECTIVE PROCESS FOR PREPARING (CYCLO)ALKYL PHENYLGLYCOLIC ACIDS | SEPRACOR INC. (US) | 2000-05-18 | — | — | WO | claimed |
| WO-2000023414-A2 | SYNTHESIS OF OPTICALLY ACTIVE CYCLOHEXYLPHENYLGLYCOLIC ACID AND ITS ESTERS | SEPRACOR INC. (US) | 2000-04-27 | — | — | WO | claimed |
| US-6025177-A | ENANTIOSELECTIVE SYNTHESIS OF CHIRAL ALPHA-HYDROXYCARBOXYLATE BY REACTING A PROCHIRAL ALPHA-KETOCARBOXYLIC ACID WITH A SINGLE ENANTIOMER OF AN N-SUBSTITUTED VICINAL AMINOALCOHOL OF SPECIFIC CYCLOHYDROCARBONS TO FORM ALPHA-HYDROXYCARBOXYLATE | SEPRACOR INC. (US) | 2000-02-15 | — | — | US | claimed |
| WO-1999050205-A2 | ASYMMETRIC GRIGNARD SYNTHESIS WITH CYCLIC 1,2 AMINOALCOHOLS | SEPRACOR INC. (US) | 1999-10-07 | — | — | WO | claimed |